ERM proteins in cancer progression

Jarama Clucas1, Ferran Valderrama

  • 1Division of Biomedical Sciences, St George's University of London, Cranmer Terrace, London SW17 0RE, UK.

Journal of Cell Science
|January 15, 2014
PubMed

Insights

Ezrin-radixin-moesin (ERM) proteins regulate cell migration and signaling. Their altered expression and location are crucial in cancer progression, promoting invasion and tumor growth.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • Ezrin-radixin-moesin (ERM) proteins link cell membranes to the actin cytoskeleton, influencing cell migration, adhesion, and polarity.
  • ERM proteins are increasingly recognized for their critical roles in cancer progression, affecting signaling pathways and cytoskeletal organization.

Purpose of the Study:

  • To review the structure, function, and regulation of ERM proteins in normal physiology and cancer.
  • To highlight the impact of ERM protein expression and localization on tumor progression, particularly in epithelial cancers.
  • To discuss recent advances in understanding the molecular mechanisms and signaling pathways involving ERM proteins in cancer.

Main Methods:

  • Literature review and commentary.
  • Analysis of existing research on ERM protein function.
  • Focus on epithelial cancers including breast, lung, and prostate.

Main Results:

  • High ERM protein expression is observed in various cancers.
  • Mislocalization of ERM proteins promotes invasive phenotypes by disrupting cell-cell contacts and growth factor signaling.
  • ERM protein dysregulation contributes to tumor progression through altered cell signaling and cytoskeletal dynamics.

Conclusions:

  • ERM proteins are key regulators of cell behavior with significant implications in cancer.
  • Altered ERM protein expression and localization are critical drivers of tumor progression and invasion.
  • Further research into ERM protein mechanisms can reveal novel therapeutic targets for epithelial cancers.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Tumor Progression02:07

Tumor Progression

3.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

6.1K